CVE-2024-33502

Description

An improper limitation of a pathname to a restricted directory ('path traversal') in Fortinet FortiManager, FortiAnalyzer versions 7.4.0 through 7.4.2 and 7.2.0 through 7.2.5 and 7.0.0 through 7.0.12 and 6.4.0 through 6.4.14 and 6.2.0 through 6.2.12 and 6.0.0 through 6.0.12 allows attacker to execute unauthorized code or commands via crafted HTTP or HTTPs requests.

Remediation

Solution:

  • Please upgrade to FortiManager version 7.4.3 or above Please upgrade to FortiManager version 7.2.6 or above Please upgrade to FortiAnalyzer version 7.4.3 or above Please upgrade to FortiAnalyzer version 7.2.6 or above

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.19%
Vendor Advisory fortinet.com
Affected: Fortinet FortiManager
Affected: Fortinet FortiAnalyzer
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-33502?
CVE-2024-33502 has been scored as a medium severity vulnerability.
How to fix CVE-2024-33502?
To fix CVE-2024-33502: Please upgrade to FortiManager version 7.4.3 or above Please upgrade to FortiManager version 7.2.6 or above Please upgrade to FortiAnalyzer version 7.4.3 or above Please upgrade to FortiAnalyzer version 7.2.6 or above
Is CVE-2024-33502 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-33502 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-33502?
CVE-2024-33502 affects Fortinet FortiManager, Fortinet FortiAnalyzer.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.